BiochemProbe — Life Science Research Reagents

R-268712 free base · Synonyms: R 268712 · R268712

R-268712 is an orally active and selective ALK-5 inhibitor.

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

R-268712 structure

CAS No.: 879487-87-3

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
250 mg USD 420.00 BP-02096-250mg In stock Get quote
500 mg USD 670.00 BP-02096-500mg In stock Get quote
1 g USD 1,075.00 BP-02096-1g In stock Get quote
2 g USD 1,730.00 BP-02096-2g In stock Get quote
3 g USD 2,065.00 BP-02096-3g In stock Get quote
5 g USD 2,750.00 BP-02096-5g In stock Get quote
10 g USD 4,400.00 BP-02096-10g In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

R-268712 is an orally active and selective ALK-5 inhibitor, with an IC50 of 2.5 nM. R-268712 inhibits the phosphorylation of Smad3 in a dose-dependent manner with an IC50 of 10.4 nM. R-268712 suppresses glomerulonephritis as well as glomerulosclerosis by inhibiting TGF-β signaling, which can be used in studies of renal fibrosis and cancer .

Biological activity

In Vitro R-268712 (3, 10, 30, 100, 300 nM; 1 h) inhibits the phosphorylation of Smad3 in a dose-dependent manner with an IC50 of 10.4 nM in HFL-1 cells[1]. R-268712 (3, 10, 30, 100, 300 nM; 72 h) inhibits myofibroblast transdifferentiation (MTD) from fibroblasts in a dose-dependent manner without inhibition of cell growth in HFL-1cells. In Vivo R-268712 (0.3, 1, 3, 10 mg/kg; p.o.; single) shows AUC0-24 values of 0.075, 0.28, 1.6 and 8.2 μg h/mL for dosages of 0.3, 1, 3, 10 mg/kg, respectively. R-268712 (1, 3, 10 mg/kg; p.o.; single daily for 3 days) inhibits renal luciferase activity in a dose-dependent manner in UUO model. R-268712 (0.3, 1 mg/kg; p.o.; single daily for 33 days) shows renoprotective effects (improves and maintains renal function as well as inhibits glomerular sclerosis) on Thy1 nephritis model when at dosage of 1 mg/kg.

Identifiers

SMILES
CC1=CC=CC(=N1)C1=C(C=NN1)C1=CC(C2=CN(CCO)N=C2)=C(F)C=C1
InChIKey
JQGOCCALXFSRHZ-UHFFFAOYSA-N

Specifications

MW (average)
363.3882
Formula
C20H18FN5O
CAS No.
879487-87-3
Physical state
Solid
Color
White to light yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

References

[1]. Terashima H, et al. Attenuation of pulmonary fibrosis in type I collagen-targeted reporter mice with ALK-5 inhibitors. Pulm Pharmacol Ther. 2019 Feb;54:31-38.
[2]. Terashima H, et al. R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model. Eur J Pharmacol. 2014 Jul 5;734:60-6.
[3]. Wang H, et al. Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage. Eur J Med Chem. 2020 Apr 1;191:112154.

Same research area

Search Cardiovascular Disease

Recently viewed